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Objectives: To determine the outcome of arterial reconstructive procedures, we audited retrospectively peripheral bypass 
grafts and endarterectomies performed between 1982 and 1990. 
Materials and methods: 1005 peripheral arterial procedures were performed in 862 lower limbs in 782 patients. 62% of 
the limbs were critically ischaemic. The procedures include 565 bypasses, 346 endarterectomies and 94 combinations of 
both. 30% of the patients were women. Follozu-up information was obtained from practitioners in charge of post-hospital 
care by questionnaires. Factors potentially affecting patency were investigated by multivariate analysis and patency rates 
were calculated by life-tables. 
Main results: Overall secondary patency was 61% at one year and 35% at 5 years. Bypasses and endarterectomies n 
women yielded lower patency rates than in men (49% vs. 67% at I year, p < 0.001). The relative risk of failure in women 
as compared to men was 1.30. The risk of failure was further increased by "redo" surgery (relative risk 1.51), diabetes 
(1.40), critical ischaemia (1.34) and crural procedures (1.34). 
Conclusions: Secondary patency rates were significantly lower in women than in men. This is in agreement with some 
other studies, although gender has gained little attention as a risk factor in vascular surgery. 
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Introduction 
Quality control is an increasingly important issue in 
patient care. A particular need for quality control in 
vascular surgery has been demonstrated bythe results 
of the "Maryland study', 1 although this provoked 
ample controversy. A sharp increase in the number of 
percutaneous transluminal angioplasties (PTAs) per- 
formed in Maryland over 10 years was reported. 
Simultaneously, the number of peripheral bypass 
operations doubled from 1979 to 1989 (from 32 to 65 
per 100 000). In the same period, the number of lower- 
extremity amputations remained unchanged (around 
30 per 100 000). 
In Switzerland, the number of peripheral bypass 
procedures increased nearly threefold between 1979 
and 1989 (from 394 to 1135, estimated from 13 to 34 per 
100 000). 2 Over the same period, the number of major 
lower-extremity amputations almost doubled (from 
233 to 465, estimated from 7.7 to 14 per 100000). 
Angioplasty procedures, although well established in 
Switzerland, were not registered uring this period. 
At Zurich University Hospital, particular patient 
groups had been studied on a number of occasions. 
However, no systematic surveillance program was 
followed until 1991 and the overall outcome of 
revascularisation procedures was unknown. There- 
fore, we audited retrospectively the results of periph- 
eral bypass and endarterectomy surgery carried out 
between 1982 and 1990 in order to determine long- 
term patency rates and affecting factors. 
Material and Methods 
All peripheral arterial reconstructions carried out from 
1982 to 1990 were identified from the data base and 
the year books of the Swiss Hospital Association 
(VESKA) by means of pertinent code numbers (260: 
endarterectomy, 261: bypass). In addition, graft throm- 
bectomies (259.110) and major lower-extremity ampu- 
tations (783: below-knee, 743: above-knee) were 
recorded. Procedures below the inguinal igament and 
those originating from the iliacs and ending at 
infrainguinal evels were included. Basic data was 
taken from case sheets and stored in a computer data 
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base. This included patient identification, risk factors, 
diagnosis (occlusive disease, aneurysm, entrapment, 
trauma), present complaint (claudication, rest pain, 
tissue loss), date of surgery, operating surgeon, local- 
isation of endarterectomies and bypasses, bypass 
materials, complications (haemorrhage, occlusion, 
infection) and reoperations. Reoperations were classi- 
fied as "revisions", when the major part of the 
previous procedure remained unchanged, and as 
"redo" procedures, if major parts were replaced. In the 
case of a "redo" operation, the previous procedure 
was considered as failed. 
Questionnaires regarding patients who had been 
discharged with patent bypasses were sent to the 
practitioners who were in charge of post-hospital care. 
They were asked to communicate their clinical find- 
ings and their judgement of the patency and the 
patency interval. Further questions concerned later 
revascularisation procedures and amputations of the 
same limb, subsequent disease and death. 
Secondary patency and patency intervals were 
appraised by the first author who was uninvolved 
with all operations. In order to avoid bias by personal 
preference, a layout was used on the computer screen 
in which data regarding surgical techniques, 
employed materials and operating surgeons were 
hidden. 
Angiographic evidence, increase of the ankle-bra- 
chial index by 0.15 or more, palpable distal pulse or 
autoptic evidence were taken as evidence of patency. 3 
In the absence of hard criteria, definitive, marked 
improvement of symptoms by two categories as 
defined by the Ad Hoc Committee 3 was accepted as an 
indication of patency. Patent reconstructions ot fol- 
lowed beyond October 1st, 1992, were considered lost 
to follow-up. 
Secondary patency rates were calculated by com- 
puterized standard life-table analysis. 3'4 Patency rates 
with standard errors exceeding 10% were disre- 
garded 3'5 and were consequently omitted in the 
subsequent text and figures unless stated otherwise. 
Life-tables were calculated for various subgroups. For 
comparison of any two groups the logrank test 6 was 
used. Patients between 57.5 and 82.5 years of age at 
the time of surgery were divided into five age groups 
for comparison. Age group "60" comprises all patients 
between 57.5 and 62.5 years of age, age group "65" all 
patients between 62.5 and 67.5 etc. Factors affecting 
patency were further identified by multivariate sur- 
vival analysis using the Cox proportional hazards 
model (BMDP2L, Statistical Software Inc.) 7. Patency 
and patency intervals were introduced as variates. As 
covariates we used patient age and sex, history of 
smoking and diabetes, critical vs. non-critical ischae- 
mia, right vs. left lower extremity, endarterectomy vs. 
bypass, crural vs. non-crural bypass and primary vs. 
"redo" procedures, and operating surgeons. The influ- 
ence of factors affecting patency was expressed as the 
relative risk of failure in a particular subgroup as 
compared to the complementary group. 
Results 
Pat ients and procedures 
A total of 1239 consecutive procedures were identified 
as endarterectomies and/or peripheral bypass opera- 
tions by the relevant code numbers. However, 234 
were excluded as they were revisions or "redo" 
operations after procedures carried out before 1982. 
The remaining 1005 procedures in 862 lower limbs in 
782 patients were further analysed. Seven hundred 
and one procedures were performed in men and 304 
(30.2%) in women (Table 1). Age ranged from 19 to 92 
years, the youngest patients being treated for trauma. 
Average age was 68.5 years (+ 11.1 SD). On average, 
men were 67 years old and women 73. The difference 
in age between men and women was significant (p < 
0.0001). 
Two hundred and fifty-four patients with 339 
procedures (33.7%) were known to be cigarette smok- 
ers. The prevalence of smoking was 40% for proce- 
dures in men and 19% in women.Two hundred and 
nineteen patients with 293 procedures (29.2%) had 
diabetes. The prevalence of diabetes was 24% for 
procedures in men and 41% in women. Fifty-six 
individuals with 79 procedures (7.9%) were smokers 
and diabetics (Table 1). Indications for surgery were 
ischaemic tissue loss in 389 procedures (38.7%), rest 
pain in 234 (23.3%), non-healing ulcers in claudicants 
in 37, severe claudication in 171 and moderate 
claudication in 58 (Table 1). One hundred and forty- 
four procedures were carried out for acute ischaemia, 
105 for peripheral aneurysms, 11 for trauma and five 
for popliteal entrapment. 
Among 1005 procedures, 565 were bypasses alone 
(390 in men and 175 in women). Of these, 346 were 
endarterectomies (M 256, W 90) and 94.were combina- 
tions of both (M 55, W 39). The total number of 
bypasses was 649. Five hundred and seventeen proce- 
dures dealt with the right leg and 482 with the left leg. 
The side of the body of the remaining six procedures 
was not evident from available data. One hundred 
and forty-two operations were "redo" procedures 
(14%) (Table 1). Two hundred and fifty-seven bypass 
grafts (40%) were autologous veins, 231 human 
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umbilical veins (HUV), 34 PTFE, 21 Dacron and 52 
composite grafts were used. For the remaining rafts, 
less common (e.g. homologous veins) or not clearly 
specified materials were used. In 259 bypasses, the 
popliteal artery was the site of the distal anastomosis; 
100 above and in 159 below the knee (Table 1). The 
anterior tibial artery was used 93 times, the posterior 
tibial artery 49 and the peroneal artery 120. Nineteen 
bypasses were anastomosed to pedal arteries. Of 346 
endarterectomies, 233 were "semi-open" procedures 
using ring strippers. Due to numerous combinations 
of localisation, extent and technique, we didn't further 
subdivide the endarterectomy cohort. 
Fifteen surgeons performed 20 or more operations 
each. The most involved surgeons carried out 266, 95, 
89, 74 and 49 operations, respectively. A total of 597 
questionnaires were mailed. Of these, 345 (58%) were 
returned with useful information; 74 were not sat- 
isfactory; 79 were returned blank and 99 were not 
returned at all. 
postoperative haemorrhage or haematoma (bypass 
13%, endarterectomy 11%); 11% had reversible occlu- 
sions during the first month (B 13%, E 7%) and 3% at 
a later stage (B 4%, E 1%). Seven percent of all 
procedures were followed by mild to moderate infec- 
tion (B 8%, E 5%) and 2% by severe (B 4%, E 1%). In 
summarN complications were less frequent after 
endarterectomies than after bypass procedures. Mor- 
tality was 5.0% at 1 month, 4.1% in men and 7.0% in 
women. Over the entire period of observation, 234 
deaths were reported. Actuarial survival rates were 
86% at 1 year, 46% at 5 years and 21% at 10 years, 
respectively. 
Three hundred and forty-five legs had an uninter- 
rupted follow-up. Of these, 150 (43%) were ultimately 
amputated: 87 below the knee, 13 primarily below and 
secondarily above the knee, and 50 primarily above 
the knee. At the time of inquirN 27 legs suffered from 
necrosis (8%), 14 from rest pain (4%), 26 from severe 
(7.5%) and 46 from mild to moderate claudication 
(13%). 121 limbs (35%) were free of symptoms. 
Complications and mortality 
Twelve percent of the procedures were followed by 
Table 1. Patient characteristics and technical features of 1005 
infrainguinal arterial reconstructions i  men and women 
Men Women 
Reconstruction ( ) 701 304 
Patient age distribution 
Mean (years) 67 73 
60-year-olds (57.5-62.5) 14% 8% 
65-year-olds (62.5~7.5) 20% 10% 
70-year-olds (67.5-72.5) 17% 14% 
75-year-olds (72.5-77.5) 16% 29% 
80-year-olds (77.5-82.5) 13% 16% 
Risk factors 
Smoking 40% 19% 
Diabetes 24% 41% 
Indications 
Tissue loss 37% 56% 
Others 63% 44% 
Technical features 
Endarterectomy alone 37% 30% 
"Redo" surgery 12% 18% 
Bypass grafts 63% 70% 
Bypass grafts (n) 445 214 
Suprageniculate 15%* 14%* 
Infrageniculate 23 %* 23 % * 
Crural 36%* 44%* 
Others 26%* 18%* 
Autologous vein graft 44%* 29 % * 
Other graft materials 56%* 71% * 
Percentages refer to the total number of reconstructions carried out in 
men (701) or women (304), respectively. In the last section concerning 
bypass urger~ per cent refer to the number of bypasses carried out 
in men (445) or women (214, right column), respectively, and are 
marked by*. 
Life-table analysis of secondary patency 
In the first month, 156 reconstructions failed irreversi- 
bly; 282 were lost to follow-up; 44 were withdrawn 
from observation due to death. Over a period of 11 
years, 410 reconstructions failed. Overall patency was 
61% (+ 2.1% SE) at 1 year, 35% (+ 2.92%) at 5 years 
and 25% ( + 5.2%) at 10 years. There was no significant 
difference between right and left legs. In men, secon- 
dary patency rates of all procedures together were 
67%, 41%, and 27% at 1, 5 and 10 years, respectivel~ as
compared to 49%, 25% and 14% in women (Fig. 1). In 
bypass grafts, secondary patency rates at I and 5 years 
were 61% and 35% in men and 44% and 23% in 
women, respectively. In autologous bypass grafts, 
corresponding figures were 67% and 45% in men and 
100 
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Fig. 1. Overall secondary patency rates of men (701) and women 
(305). S.E. < 10%. Arterial reconstructions i  men yielded sig- 
nificantly higher patency rates (p < 0.001). (B) men; (©) women. 
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53% and 34% in women, respectively (p > 0.05). In 
summar)5 men had significantly higher patency rates 
than women, both after endarterectomies and bypass 
grafting (p < 0.001). 
Secondary patency rates for five separate age 
groups at 1 and 5 years were as follows: In 60-year- 
olds, 61% and 34%; in 65-year-olds 67% and 40%; in 
70-year-olds 68% and 41%; in 75-year-olds 57% and 
28%; and in octogenarians 48% and 30%. No sig- 
nificant difference was found between individual age 
groups. Cigarette smokers had secondary patency 
rates of 65% and 38% at I and 5 years, respectively; in
diabetics, 49% and 23% of all reconstructions were 
patent; in non-smokers-non-diabetics, 64% and 44% 
were patent. Patency rates in diabetics were sig- 
nificantly lower than in non-diabetics (p < 0.001). 
Secondary patency rates in claudicants were 86% and 
49% at 1 and 5 years; corresponding figures in limbs 
with ischaemic rest pain were 63% and 38% and in 
limbs with ischaemic tissue loss 46% and 25% (Fig. 2). 
Differences were significant (p < 0.005). 
"Redo" operations yielded significantly lower sec- 
ondary patency rates than primary procedures, e.g. 
35% vs.  61% and 27% vs.  48% at 1 and 5 years, 
respectively (p < 0.001). Endarterectomies yielded 
higher patency rates than bypass grafting, e.g. 73% vs .  
55% and 43% vs.  31% at 1 and 5 years, respectively. 
According to multivariate analysis, these differences 
were not significant and rather due to unequal risk 
selection, e.g., only a minority of endarterectomies 
(41%), but the majority of bypasses (67%) were carried 
out for critical ischaemia. Furthermore, endarter- 
ectomies were usually more proximal. Reversed auto- 
logous vein bypasses yielded secondary patency rates 
of 60% and 38% at 1 and 5 years, respectively. 
Corresponding rates with HUV grafts were 51% and 
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Fig. 2. Secondary patency rates of arterial reconstructions for 
claudication vs .  rest pain vs. necrosis, s.~. < 10%. Dark symbols = 
critical ischaemia. The more severe preoperative ischaemia, the 
lower the patency rate. Differences are significant (p < 0.005). (C)) 
claudication; (ll) rest pain; (A) necrosis. 
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Fig. 3. Secondary patency rates of bypasses by bypass materials, s.E. 
< 10%. Dark symbols = non-autologous materials. Results were 
not significantly different (small number of PTFE grafts). ((9) Rev 
veins (208); ( i )  HUV (231); (&) PTFE (34). 
25%. The difference fell short of significance, even if 
crural bypasses were analysed individually. Secon- 
dary patency rates of HUV grafts were slightly better 
than those of PTFE grafts, but the number of the latter 
was small and the difference was not significant (Fig. 
3). Patency of bypass grafts was further affected by the 
recipient vessels (Fig. 4). Suprageniculate popliteal 
bypasses had secondary patency rates of 61% and 36% 
at i and 5 years, respectively; infrageniculate popliteal 
61% and 47%; anterior tibial 36% and 11%; posterior 
tibial 42% and 18%; peroneal 56% and 24%. Popliteal 
bypass grafts reached significantly higher patency 
rates than crural (p < 0.05). Differences between 
peroneal, anterior and posterior tibial arteries were 
not significant. 
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Fig. 4. Patency rates of bypasses by recipient vessels, s.~. < 10%. 
Light symbols = popliteal, black symbols = crural. Initial patient 
numbers are in parenthesis. Popliteal bypasses yielded significantly 
higher patency rates than crural (p < 0.05). (©) P. supragen (96); (K]) 
P. infragen (153); (O) tib. ant. (93); ( i )  Tib. post. (42); (A) fibularis 
(121). 
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Table 2. Predictors and relatice risk of failure in 1005 infrainguinal 
arterial reconstructions 
Relative risk 95% confidence interval 
Female sex 1.302" 
Age (+1 year) 1.007 
Left side 0.978 
Critical ischaemia 1.336" 
Bypass 1.415 
Diabetes 1.403" 
Smoking 1.055 
Crural 1.343" 
Redo 1.510" 
1.047-1.618 
0.996-1.018 
0.803-1.193 
1.060-1.683 
0.189-10.597 
1.139-1.731 
0.836-1.331 
1.043-1.729 
1.177-1.938 
Multivariate analysis 
Patency was adversely affected to a significant extent 
by female gender, diabetes, critical preoperative 
ischaemia, crural procedures and "redo" procedures. 
In "redo" procedures, the relative risk of occlusion 
was 1.51, in diabetics 1.40, in procedures for rest pain 
or ischaemic necrosis 1.34 as compared to claudica- 
tion. In crural procedures the relative risk of occlusion 
was 1.34 in relation to more proximal procedures and 
in women it was 1.30 in relation to men. Conversely, 
patient age, history of smoking and right vs. left lower 
extremity did not significantly affect patency rates 
(Table 2). 
Endarterectomies eemed to fare better than 
bypasses by life-table analysis. By multivariate analy- 
sis, however, the difference was attributed to more 
proximal levels and milder preoperative symptoms 
rather than the method itself. Similarly the individual 
patency rates of five operating surgeons differed 
considerably and ranged from 50% to 81% at 1 year. 
However, differences appeared to be due to unequal 
patient selection (e.g., 79% of the bypasses carried out 
by the surgeon with the lowest patency rate were 
crural, in contrast to only 10% in the case of the 
surgeon with the highest patency rate). 
Discussion 
Methodical drawbacks are inherent in any retro- 
spective study. In the present series, follow-up was 
defective and patients who had an uneventful course 
were more prone to be lost to follow-up than those 
with occlusions, amputations or other complications. 
This may have adversely affected the mortality and 
patency rates. Therefore, comparisons between 
patency rates of subgroups within our series might be 
more reliable than comparisons with other studies. 
Patency and patency intervals were appraised by the 
first author. Personal bias can be ruled out as he was 
uninvolved with operations and appraisal of results 
was blinded as to the operating surgeon and the 
techniques and materials used. Moreover, consistency 
of appraisal was verified by comparing the outcome 
between right and left legs as it can be assumed that 
the patency rates should be identical. Indeed, secon- 
dary patency rates of right and left legs were the same 
in this series. Therefore, we feel that uncertainty of 
appraisal of individual cases was compensated for by 
the large numbers. This assumption is further sup- 
ported by the fact that factors affecting graft patency 
in our series are by and large the same as those 
identified by others. 
Secondary patency rates were lower in the present 
study than in most published contemporary series, 8"9 
mainly due to a more frequent occurrence of early 
occlusions. It is generally accepted today that occlu- 
sions during the first few weeks after surgery are 
mainly due to technical errors. Their detection by 
completion control and immediate correction contrib- 
utes to improvement of primary patency rates. In the 
further course of the first year, stenoses due to myo- 
intimal hyperplasia ccount for most failures. Post- 
procedural surveillance aims at detecting and repair- 
ing stenoses before occlusion occurs. Thus, secondary 
patency rates can be further enhanced. 1°-13 The lack of 
systematic completion control and surveillance in this 
series may further explain differences in outcome. In 
our series, autologous veins were used in only 40% of 
infrainguinal bypass grafts. The second most used 
material was HUV accounting for 36%. Autologous 
vein bypasses fared better than non-autologous. How- 
ever, secondary patency rates were not significantly 
different, even in crural bypass grafts. Graft material is 
an established factor affecting the outcome of infra- 
inguinal bypasses. Controversy exists about prefer- 
ential use of non-autologous grafts in femoropopliteal 
bypasses, especially above the knee. ~4'~5 However, it is 
generally accepted that autologous veins yield clearly 
better results than any substitute in crural bypass 
surgery. 16A7 Today, the low rate of vein utilization in 
the present series appears unusual and, presumably it 
contributed to the low patency rates. 
Twenty-nine percent of our procedures were per- 
formed in patients with diabetes. The prevalence of 
diabetes was significantly higher in women than in 
men. Secondary patency rates were significantly lower 
in patients with diabetes than in others. In the 
literature, the prevalence of diabetes associated with 
infrainguinal bypass surgery ranges from 4 to 
55%, 1s'19 Diabetes is generally accepted as a major risk 
factor for chronic arterial occlusive disease and for 
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limb loss. However, its influence on patency rates is 
still a matter of controversy. 2°-23 
In the present stud)~ 30% of procedures were 
performed in women. Female gender was found to be 
a predictor of bad outcome in two ways: Mortality 
was significantly higher in women than in men, and 
secondary patency rates were significantly lower. 
Gender has gained relatively little attention as a factor 
potentially affecting the outcome of infrainguinal 
reconstructions. 24 Magnant et al. found increased 30 
day mortality, although this was not significant, and 
significantly ower long-term graft patency in women 
than in men. 8 In two earlier studies, female sex also 
adversely affected graft patency. 25"26 In contrast, Har- 
ris et al. found that long-term autologous vein graft 
patency results in women were identical to those 
obtained in men. In our stud)~ some predictors of 
failure occurred more frequently in women than in 
men, namely critical ischaemia, diabetes, crural level 
and "redo" surgery. Nevertheless, female sex turned 
out to be an independent predictor of failure accord- 
ing to multivariate analysis. More frequent use of non- 
autologous material in women in spite of more 
frequent crural bypass levels could have contributed 
to the difference in outcome. However, patency rates 
were also lower in women where autologous vein 
grafts were used although this difference was not 
significant. It can be assumed that inlet and outlet 
vessels are, on average, smaller in women than in 
men. Possibly, this is also true for bypass veins 8 which 
could explain a lower rate of vein utilisation and 
inferior results in women. Furthermore, small vessels 
are known to bear a higher risk of occlusion than 
larger ones for several reasons. E.g., for the same 
technical imperfection, the lumen is impaired to a 
higher degree in a small than in a large vessel. The 
same is true for a given amount of myointimal 
hyperplasia. 
In the present series, severe ischaemia, recipient 
vessels and "redo" procedures were further predictors 
of failure. This is in agreement with several other 
studies, although some more recent publications 
report more favourable results in femorotibial and 
femoro pedal bypass than are obtained with below- 
knee femoropopliteal reconstructions to a diseased 
vessel. 
Following the period covered by this audit, our 
policies have been changed in several ways. System- 
atic intraoperative and post-procedural controls at 1, 
3, 6 and 12 months have been instituted. 28 Fur- 
thermore, autologous veins from typical or atypical 
sources have been used for crural bypass whenever 
possible. For infrageniculate femoropopliteal 
bypasses, the ipsilateral great saphenous vein has 
been preferred. If it was missing or inadequate, we 
have resorted to PTFE grafts. However, PTFE grafts 
have been used preferentially for suprageniculate 
popliteal bypass grafts. 14 
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